Active Control Placebo

DRUG4 trials

Sponsors

Shanghai SIMR Biotechnology Co., Ltd., Vanda Pharmaceuticals, Ecole Polytechnique Fédérale de Lausanne, National Taiwan University Hospital

Conditions

EpilepsyEpilepsy in ChildrenHealthy AgingHealthy VolunteersMild Cognitive Impairment (MCI)Peripheral Neuropathic Pain

Phase 1

A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419

CompletedNCT04494815

Shanghai SIMR Biotechnology Co., Ltd.Peripheral Neuropathic Pain

Start: 2020-09-18End: 2022-07-31Updated: 2025-08-13

Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects

CompletedNCT06323655

Vanda PharmaceuticalsHealthy Volunteers

Start: 2018-07-19End: 2018-08-28Updated: 2024-03-21

Unknown Phase

Novel Individualized Brain Stimulation, Network-based Approaches to Improve Cognition in Healthy Seniors and MCI Patients

CompletedNCT07090681

Ecole Polytechnique Fédérale de LausanneHealthy Aging, Mild Cognitive Impairment (MCI)

Start: 2023-10-01End: 2024-10-24Updated: 2025-08-07

Sleep, Music, And Research Trial 2.0

Not yet recruitingNCT07696442

National Taiwan University HospitalEpilepsy, Epilepsy in Children

Start: 2026-08-01End: 2029-12-01Target: 144Updated: 2026-07-14

Related Papers

Multifocal Noninvasive Deep Brain Stimulation to Enhance Cognition in Mild Cognitive Impairment

JAMA Network Open2026-07-06